呼吸器合胞体ウイルス診断の世界市場

呼吸器合胞体ウイルス診断の世界市場は2030年までに77億米ドルに到達

2024年に61億米ドルと推定される呼吸器合胞体ウイルス診断の世界市場は、2024年から2030年にかけてCAGR 4.0％で成長し、2030年には77億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである直接蛍光抗体法は、CAGR 3.1％を記録し、分析期間終了までに19億米ドルに達すると予測されます。迅速抗原診断検査分野の成長率は、分析期間中CAGR 3.1％と推定されます。

米国市場は17億米ドルと推定、中国はCAGR 7.2％で成長予測

米国の呼吸器合胞体ウイルス診断市場は2024年に17億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに15億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは7.2%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.7%と3.0%と予測されています。欧州では、ドイツがCAGR 2.3%で成長すると予測されています。

世界の呼吸器合胞体ウイルス診断市場- 主要動向と促進要因まとめ

なぜ呼吸器合胞体ウイルス（RSV）の早期かつ正確な診断がこれまで以上に重要なのか？

呼吸器合胞体ウイルス（RSV）は感染力の強いウイルスで、特に乳幼児、高齢者、免疫不全者に重篤な呼吸器感染症を引き起こします。RSVは依然として幼児における入院の主な原因であり、高齢者では重大な罹患率の原因となっているため、迅速で正確な診断薬に対する需要が急増しています。RSV感染の季節性は、インフルエンザやCOVID-19のような他の呼吸器疾患を模倣する能力と相まって、RSVと他のウイルス病原体を区別できる高度な診断ツールの必要性を強調しています。さらに、最近RSVの集団発生や他の呼吸器ウイルスとの併発が出現していることから、信頼性の高い診断ソリューションの緊急性がさらに高まっています。政府、ヘルスケア機関、診断企業は、早期介入を促進し、感染率を低下させ、患者の転帰を改善するために、RSV検出技術に多額の投資を行っています。

RSV診断技術の革新はどのように検出と精度を高めているか？

RSV診断の状況は、分子検査、ポイントオブケア診断、AIを活用した診断プラットフォームの登場によって大きく進化しています。ウイルス培養や直接蛍光抗体（DFA）検査などの従来の方法は、より高感度で迅速な分子アッセイに取って代わられつつあります。ポリメラーゼ連鎖反応（PCR）ベースの診断法は、RSV検出のゴールドスタンダードとして登場し、高い精度と低ウイルス量でも検出できる能力を提供しています。さらに、ループ媒介等温増幅（LAMP）などの等温増幅技術の開発により、特に資源が限られた環境において、迅速かつ費用対効果の高いRSV診断が容易になりました。画像診断とデジタル病理診断におけるAIと機械学習の統合は、検査解釈をさらに改善し、診断精度を高め、偽陰性を最小限に抑えています。RSV検査機能が進歩するにつれて、ヘルスケアプロバイダーは感染を早期に発見し、適切な治療戦略を実施する能力が向上します。

RSV診断薬の需要を牽引する市場動向とは？

RSV関連合併症に対する意識の高まりと、ポイントオブケア検査（POCT）の普及が市場拡大に大きく寄与しています。COVID-19パンデミックは、RSV、インフルエンザ、SARS-CoV-2を同時に検査し、包括的な呼吸器疾患管理を可能にするマルチプレックス呼吸器ウイルスパネルへの関心をさらに加速させています。さらに、高齢者集団におけるRSV感染の有病率の上昇により、長期療養施設や病院におけるルーチンのRSVスクリーニングの必要性が高まっています。また、自己検査キットやモバイル診断プラットフォームにより、従来のヘルスケア環境以外でも簡便にRSVを検出できるため、在宅検査や分散型検査ソリューションの拡大も牽引役となっています。さらに、RSVサーベイランス・プログラムを推進する政府のイニシアティブや、国の予防接種戦略にRSV診断法を組み込むことが、市場の成長を押し上げると予想されます。迅速で信頼性の高い呼吸器ウイルス検査に対する消費者の需要が高まる中、診断薬メーカーは検査の利便性と性能を向上させるために継続的な技術革新を行っています。

呼吸器合胞体ウイルス診断市場の主な成長促進要因は？

世界の呼吸器合胞体ウイルス診断市場の成長は、RSV感染症の発生率の増加、分子診断学の進歩、ポイントオブケアおよびホームベースの検査ソリューションに対する需要の高まりなど、いくつかの要因によって牽引されています。複数の呼吸器病原体を同時に検出できるマルチプレックス検査パネルの拡大が、市場の需要をさらに促進しています。さらに、AI主導の診断ツールやデジタル病理学プラットフォームの採用拡大が、検査の精度と効率を高めています。また、RSVサーベイランスプログラムへの投資の増加や、疾患モニタリングの改善に向けた政府主導の取り組みも市場拡大に寄与しています。さらに、RSVワクチンや抗ウイルス治療の開発が進んでいることから、補完的な診断ソリューションの需要も高まると予想されます。ヘルスケア産業が感染症管理を優先し続ける中、RSV診断薬市場は、早期発見、疾病予防、患者の転帰改善のための革新的なソリューションを提供し、持続的な成長を遂げる態勢を整えています。

セグメント

製品（直接蛍光抗体法、迅速抗原診断検査、分子診断、クロマトグラフィー免疫測定、画像診断、ゲルマイクロドロップレット、フローサイトメトリー、その他）、業界別（病院、研究所、診療所、在宅医療）

調査対象企業の例

• Abbott Laboratories
• Affymetrix（part of Thermo Fisher）
• Alere Inc.
• Becton, Dickinson and Company（BD）
• Biocartis NV
• BioMerieux Inc.
• bioMerieux SA
• Bio-Rad Laboratories Inc.
• Cepheid
• Coris BioConcept
• Danaher Corporation
• DiaSorin S.p.A.
• F. Hoffmann-La Roche Ltd
• Fast-track Diagnostics
• GenMark Diagnostics
• Grifols S.A.
• Hologic Inc.
• Luminex Corporation
• Meridian Bioscience, Inc.
• MilliporeSigma

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Respiratory Syncytial Virus Diagnostics Market to Reach US$7.7 Billion by 2030

The global market for Respiratory Syncytial Virus Diagnostics estimated at US$6.1 Billion in the year 2024, is expected to reach US$7.7 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Direct Fluorescent Antibody Method, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$1.9 Billion by the end of the analysis period. Growth in the Rapid Antigen Diagnostic Test segment is estimated at 3.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.7 Billion While China is Forecast to Grow at 7.2% CAGR

The Respiratory Syncytial Virus Diagnostics market in the U.S. is estimated at US$1.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 7.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Respiratory Syncytial Virus Diagnostics Market - Key Trends & Drivers Summarized

Why Is Early and Accurate Diagnosis of Respiratory Syncytial Virus (RSV) More Critical Than Ever?

Respiratory Syncytial Virus (RSV) is a highly contagious virus that causes severe respiratory infections, particularly in infants, the elderly, and immunocompromised individuals. As RSV remains a leading cause of hospitalizations in young children and contributes to significant morbidity in older adults, the demand for rapid and accurate diagnostics has surged. The seasonal nature of RSV infections, coupled with its ability to mimic other respiratory illnesses such as influenza and COVID-19, underscores the need for advanced diagnostic tools that can differentiate RSV from other viral pathogens. Moreover, the recent emergence of RSV outbreaks and co-infections with other respiratory viruses has further increased the urgency for reliable diagnostic solutions. Governments, healthcare institutions, and diagnostic companies are investing heavily in RSV detection technologies to facilitate early intervention, reduce transmission rates, and improve patient outcomes.

How Are Innovations in RSV Diagnostic Technologies Enhancing Detection and Accuracy?

The landscape of RSV diagnostics has evolved significantly with the advent of molecular testing, point-of-care diagnostics, and AI-powered diagnostic platforms. Traditional methods such as viral culture and direct fluorescent antibody (DFA) testing are being phased out in favor of more sensitive and rapid molecular assays. Polymerase chain reaction (PCR)-based diagnostics have emerged as the gold standard for RSV detection, offering high accuracy and the ability to detect even low viral loads. Additionally, the development of isothermal amplification techniques, such as loop-mediated isothermal amplification (LAMP), has facilitated rapid and cost-effective RSV diagnosis, particularly in resource-limited settings. The integration of AI and machine learning in diagnostic imaging and digital pathology is further improving test interpretation, enhancing diagnostic precision, and minimizing false negatives. As RSV testing capabilities advance, healthcare providers are better equipped to detect infections early and implement appropriate treatment strategies.

What Market Trends Are Driving the Demand for RSV Diagnostics?

The growing awareness of RSV-related complications and the increasing adoption of point-of-care testing (POCT) have significantly contributed to market expansion. The COVID-19 pandemic has further accelerated interest in multiplex respiratory virus panels, which simultaneously test for RSV, influenza, and SARS-CoV-2, enabling comprehensive respiratory disease management. Additionally, the rising prevalence of RSV infections in aging populations has increased the need for routine RSV screening in long-term care facilities and hospitals. The expansion of home-based and decentralized testing solutions has also gained traction, with self-testing kits and mobile diagnostic platforms allowing for convenient RSV detection outside traditional healthcare settings. Furthermore, government initiatives promoting RSV surveillance programs and the integration of RSV diagnostics into national immunization strategies are expected to boost market growth. As consumer demand for fast and reliable respiratory virus testing rises, diagnostic manufacturers are continuously innovating to improve test accessibility and performance.

What Are the Key Growth Drivers of the Respiratory Syncytial Virus Diagnostics Market?

The growth in the global respiratory syncytial virus diagnostics market is driven by several factors, including the increasing incidence of RSV infections, advancements in molecular diagnostics, and the rising demand for point-of-care and home-based testing solutions. The expansion of multiplex testing panels, which enable simultaneous detection of multiple respiratory pathogens, has further fueled market demand. Additionally, the growing adoption of AI-driven diagnostic tools and digital pathology platforms is enhancing test accuracy and efficiency. The rising investment in RSV surveillance programs and government-led initiatives to improve disease monitoring are also contributing to market expansion. Furthermore, the ongoing development of RSV vaccines and antiviral treatments is expected to drive demand for complementary diagnostic solutions. As the healthcare industry continues to prioritize infectious disease management, the RSV diagnostics market is poised for sustained growth, offering innovative solutions for early detection, disease prevention, and improved patient outcomes.

SCOPE OF STUDY:

The report analyzes the Respiratory Syncytial Virus Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry, Others); Vertical (Hospitals, Laboratory, Clinics, Homecare)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 37 Featured) -

• Abbott Laboratories
• Affymetrix (part of Thermo Fisher)
• Alere Inc.
• Becton, Dickinson and Company (BD)
• Biocartis NV
• BioMerieux Inc.
• bioMerieux SA
• Bio-Rad Laboratories Inc.
• Cepheid
• Coris BioConcept
• Danaher Corporation
• DiaSorin S.p.A.
• F. Hoffmann-La Roche Ltd
• Fast-track Diagnostics
• GenMark Diagnostics
• Grifols S.A.
• Hologic Inc.
• Luminex Corporation
• Meridian Bioscience, Inc.
• MilliporeSigma

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Respiratory Syncytial Virus Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of RSV Infections Among Infants and Elderly Populations Drives Diagnostic Demand
  • Expansion of Hospital-Based Respiratory Surveillance Programs Throws the Spotlight on Rapid RSV Testing
  • Increased Adoption of Multiplex Molecular Panels Enhances Detection Accuracy for Co-Infections Including RSV
  • Growth in Point-of-Care Diagnostics Strengthens Business Case for CLIA-Waived RSV Test Kits
  • Regulatory Approvals for Molecular and Antigen-Based RSV Tests Expand Diagnostic Options
  • Technological Advancements in Isothermal Amplification and PCR Accelerate Time-to-Result for RSV Detection
  • Rise in Pediatric Outpatient Visits During Seasonal Peaks Spurs Demand for Rapid Lateral Flow Assays
  • Public Health Surveillance Initiatives Strengthen RSV Testing Infrastructure and Lab Capacity
  • Growth in Home Testing and Telemedicine Platforms Supports Market for Self-Administered RSV Diagnostics
  • OEM Partnerships With Clinics and Urgent Care Centers Drive Adoption of RSV Testing Solutions
  • Emphasis on Infection Control and Early Isolation Drives Utilization of Rapid RSV Screening in Emergency Departments
  • Expansion of Test Panels Including Flu, COVID-19, and RSV Enhances Value Proposition of Respiratory Syndromic Testing
  • Increased Awareness Among Pediatricians and Family Physicians Supports Broader Adoption of RSV Testing
  • Integration of Diagnostic Results With EMR Systems and Digital Health Tools Improves Case Tracking
  • Public Funding for Pediatric Infectious Disease Research Stimulates RSV Diagnostic Development
  • Growth in Long-Term Care Facility Monitoring Programs Expands Use of RSV Testing in Geriatric Populations
  • Inclusion of RSV Testing in School Health Programs Opens New Application Channels
  • Availability of FDA-Approved RSV Diagnostics Enhances Reimbursement Pathways in the U.S.
  • R&D in RSV Biomarker and Antibody Detection Technologies Drives Diagnostic Innovation
  • Global Surveillance and Vaccine Pipeline Progression Spurs Parallel Growth in Testing Infrastructure
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Respiratory Syncytial Virus Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Respiratory Syncytial Virus Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Direct Fluorescent Antibody Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Direct Fluorescent Antibody Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Direct Fluorescent Antibody Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Rapid Antigen Diagnostic Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Rapid Antigen Diagnostic Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Rapid Antigen Diagnostic Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Chromatographic Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Chromatographic Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Chromatographic Immunoassay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Diagnostic Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Diagnostic Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Diagnostic Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Gel Microdroplets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Gel Microdroplets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Gel Microdroplets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Flow Cytometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Flow Cytometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Flow Cytometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Laboratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Homecare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Homecare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Homecare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Respiratory Syncytial Virus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• JAPAN
  • Respiratory Syncytial Virus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• CHINA
  • Respiratory Syncytial Virus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 59: China Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• EUROPE
  • Respiratory Syncytial Virus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Respiratory Syncytial Virus Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Europe 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• FRANCE
  • Respiratory Syncytial Virus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 74: France Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: France Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: France 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 77: France Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: France 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• GERMANY
  • Respiratory Syncytial Virus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 80: Germany Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Germany Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Germany 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 83: Germany Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Germany Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Germany 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 86: Italy Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Italy Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Italy 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 89: Italy Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Italy Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Italy 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Respiratory Syncytial Virus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 92: UK Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: UK Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: UK 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 95: UK Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: UK Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: UK 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 98: Spain Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Spain Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Spain 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 101: Spain Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Spain Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Spain 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 104: Russia Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Russia Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Russia 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 107: Russia Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Russia Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Russia 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Rest of Europe Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Rest of Europe 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Rest of Europe Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Rest of Europe 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Respiratory Syncytial Virus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 117: Asia-Pacific Historic Review for Respiratory Syncytial Virus Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Asia-Pacific 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Asia-Pacific Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Asia-Pacific 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Asia-Pacific Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Asia-Pacific 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Respiratory Syncytial Virus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 125: Australia Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Australia Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Australia 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 128: Australia Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Australia Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Australia 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• INDIA
  • Respiratory Syncytial Virus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 131: India Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: India Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: India 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 134: India Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: India Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: India 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 137: South Korea Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: South Korea Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: South Korea 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 140: South Korea Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: South Korea Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: South Korea 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Asia-Pacific Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Asia-Pacific 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Asia-Pacific Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Asia-Pacific 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Respiratory Syncytial Virus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 149: Latin America Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 150: Latin America Historic Review for Respiratory Syncytial Virus Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Latin America 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 152: Latin America Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Latin America Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Latin America 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 155: Latin America Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Latin America Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Latin America 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 158: Argentina Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Argentina Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Argentina 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 161: Argentina Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Argentina Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Argentina 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 164: Brazil Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Brazil Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Brazil 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 167: Brazil Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Brazil Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Brazil 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 170: Mexico Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Mexico Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Mexico 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 173: Mexico Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Mexico Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Mexico 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Latin America Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Rest of Latin America 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 179: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Latin America Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Latin America 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Respiratory Syncytial Virus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 182: Middle East Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 183: Middle East Historic Review for Respiratory Syncytial Virus Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Middle East 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 185: Middle East Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Middle East Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Middle East 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 188: Middle East Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Middle East Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Middle East 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 191: Iran Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Iran Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Iran 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 194: Iran Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Iran Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Iran 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 197: Israel Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Israel Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Israel 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 200: Israel Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Israel Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Israel 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Saudi Arabia Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Saudi Arabia 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 206: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Saudi Arabia Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Saudi Arabia 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 209: UAE Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: UAE Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: UAE 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 212: UAE Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: UAE Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: UAE 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Rest of Middle East Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Rest of Middle East 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 218: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Rest of Middle East Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Rest of Middle East 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
• AFRICA
  • Respiratory Syncytial Virus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 221: Africa Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Africa Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Africa 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
  • TABLE 224: Africa Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Africa Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Africa 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030

IV. COMPETITION